Drugmakers Halt Autoimmune Trials After Deaths, Life-Threatening Side Effects

SummaryAI generated

Several pharmaceutical companies announced the suspension of trials for drugs used to treat autoimmune diseases due to patient deaths and severe side effects during clinical trials. This decision was based on a re-evaluation of safety, aimed at protecting the subjects and further reviewing the trial protocols.

Related eventsRELATED EVENTS

2026-09-09 05:29OpenAI claims huge maths breakthrough on a famed ‘Millennium Problem’
2026-09-09 06:11OpenAI claims to have solved the Navier-Stokes equation problem, but its originality is questioned by the academic community
2026-09-08 22:00Google DeepMind Maps 9 Billion Possible DNA Variants

Key entitiesKEY ENTITIES

Bristol MyersNovartis

Coverage · reports per dayLANGUAGE SPLIT

Entity relations

SignalsSIGNALS

Keyword heat

Novartis1
Bristol Myers1

All reports (1)SOURCES

↗

W WSJ Tech (WSJD) en 2026-09-04 06:00

Novartis and Bristol Myers have suspended clinical trials for autoimmune diseases due to the therapy causing deaths and life-threatening side effects. This suspension is aimed at urgently investigating why a promising treatment has become high-risk.